217
Participants
Start Date
July 31, 2007
Primary Completion Date
May 31, 2008
Study Completion Date
May 31, 2008
methylphenidate transdermal system
dose optimization of 4 doses of the MTS transdermal patch over the same duration of wear
Placebo
Placebo patch
Melmed Center, Scottsdale
Bay Area Research Institute, Lafayette
Elite Clinical Trials Inc., Wildomar
Sarkis Clinical Trials, Gainesville
Miami Research Associates, South Miami
Northwest Behavioral Research Ctr, Roswell
Mountain West Clinical Trials, LLC, Eagle
Vince and Associates Clinical Research, Overland Park
Shire Clinical Research Site, Lexington
Four Rivers Clinical Research, Inc., Paducah
Rochester Center for Behavioral Medicine, Rochester Hills
Clinical Neurophysiology Services, PC, Troy
CRI Worldwide, Clementon
Triangle Neuropsychiatry, Durham
Dakota Clinic/Innovis health, Fargo
Odyssey Research, Minot
University Hospitals Case Medical Center, Cleveland
Oregon Center for Clinical Investigations, Inc., Eugene
OCCI, Inc, Portland
Shire Clinical Research Site, Media
CRI Worldwide, Philadelphia
Rhode Island Hospital, Providence
CNS Healthcare, Memphis
FutureSearch Trials, Austin
Claghorn-Lesem Research, Ltd., Bellaire
Westex Clinical Investigations, Lubbock
Cerebral Research, LLC, San Antonio
Vermont Clinical Study Center, Burlington
NeuroScience, Inc., Herndon
Adolescent Health Center, Midlothian
Northwest Clinical Research Center, Friday Harbor
Eastside Therapeutic Resource, Kirkland
Lead Sponsor
Noven Therapeutics
INDUSTRY